UNC-Chapel Hill spinout Falcon Therapeutics has raised a seed round from unnamed backers.

UT Dallas spinout Cersci has raised approximately $4m to advance its non-opioid painkiller into human clinical trials by the end of next year.

The University of Hong Kong spinout is working on AI-based language processing for call centres to optimise the analysis of their phone records.

SoftBank Vision Fund is seeking to invest up to $300m in dogsitting app developer Wag, which had initially set a $100m target for its next round.

Jnana has raised $50m in a series A round backed by Pfizer and AbbVie to continue development of its protein drug discovery platform.

Mastercard and the BBVA-backed Propel Venture Partners have contributed to a series B round that will support product development and growth.

MoA Technology has started developing pesticides and has now been backed by the Parkwalk Opportunities Fund.